IL97656A - History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them - Google Patents

History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them

Info

Publication number
IL97656A
IL97656A IL9765691A IL9765691A IL97656A IL 97656 A IL97656 A IL 97656A IL 9765691 A IL9765691 A IL 9765691A IL 9765691 A IL9765691 A IL 9765691A IL 97656 A IL97656 A IL 97656A
Authority
IL
Israel
Prior art keywords
dione
dihydro
dipropyl
compound according
purine
Prior art date
Application number
IL9765691A
Other languages
English (en)
Hebrew (he)
Other versions
IL97656A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL97656A0 publication Critical patent/IL97656A0/xx
Publication of IL97656A publication Critical patent/IL97656A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9765691A 1990-03-26 1991-03-22 History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them IL97656A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (2)

Publication Number Publication Date
IL97656A0 IL97656A0 (en) 1992-06-21
IL97656A true IL97656A (en) 1996-06-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9765691A IL97656A (en) 1990-03-26 1991-03-22 History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them

Country Status (22)

Country Link
US (1) US5047534A (de)
EP (1) EP0449175B1 (de)
JP (1) JP3181305B2 (de)
KR (1) KR100195368B1 (de)
CN (1) CN1032815C (de)
AR (1) AR247887A1 (de)
AT (1) ATE156130T1 (de)
AU (1) AU632914B2 (de)
CA (1) CA2038747C (de)
DE (1) DE69127010T2 (de)
DK (1) DK0449175T3 (de)
ES (1) ES2107431T3 (de)
FI (1) FI98461C (de)
GR (1) GR3025135T3 (de)
HU (1) HU208824B (de)
IE (1) IE910982A1 (de)
IL (1) IL97656A (de)
NO (1) NO177591C (de)
NZ (1) NZ237484A (de)
PH (1) PH27511A (de)
PT (1) PT97133B (de)
ZA (1) ZA912038B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
US5840729A (en) * 1993-02-26 1998-11-24 Merrell Pharmaceuticals Inc. Xanthine derivatives as adenosine A1 receptor antagonists
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
CN1043473C (zh) * 1993-05-06 1999-05-26 默里尔多药物公司 8位取代黄嘌呤作为选择性腺苷受体药物
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
CN1787821A (zh) * 2003-06-10 2006-06-14 协和发酵工业株式会社 一种治疗焦虑症的方法
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung

Also Published As

Publication number Publication date
NO177591B (no) 1995-07-10
FI98461C (fi) 1997-06-25
NZ237484A (en) 1993-10-26
NO177591C (no) 1995-10-18
CN1055181A (zh) 1991-10-09
CN1032815C (zh) 1996-09-18
FI98461B (fi) 1997-03-14
ZA912038B (en) 1991-12-24
PT97133B (pt) 1998-07-31
HUT56570A (en) 1991-09-30
DE69127010D1 (de) 1997-09-04
AR247887A1 (es) 1995-04-28
DK0449175T3 (da) 1998-02-23
DE69127010T2 (de) 1997-11-13
NO911200L (no) 1991-09-27
CA2038747C (en) 2002-05-28
AU632914B2 (en) 1993-01-14
CA2038747A1 (en) 1991-09-27
KR910016752A (ko) 1991-11-05
FI911420A0 (fi) 1991-03-25
EP0449175B1 (de) 1997-07-30
IE910982A1 (en) 1991-10-09
JPH04221384A (ja) 1992-08-11
ATE156130T1 (de) 1997-08-15
FI911420A (fi) 1991-09-27
ES2107431T3 (es) 1997-12-01
EP0449175A3 (en) 1993-01-20
PH27511A (en) 1993-08-18
US5047534A (en) 1991-09-10
HU208824B (en) 1994-01-28
IL97656A0 (en) 1992-06-21
NO911200D0 (no) 1991-03-25
JP3181305B2 (ja) 2001-07-03
AU7353791A (en) 1991-10-03
KR100195368B1 (ko) 1999-06-15
EP0449175A2 (de) 1991-10-02
GR3025135T3 (en) 1998-02-27
PT97133A (pt) 1991-12-31

Similar Documents

Publication Publication Date Title
CA2024381C (en) Xanthine compounds
EP1116722B1 (de) [1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-DERIVATE
EP0203721A2 (de) 8-Phenylxanthine
US5047534A (en) Selective adenosine receptor agents
CA2155130C (en) Xanthine derivatives as adenosine a1 receptor antagonists
JP2954971B2 (ja) 選択的アデノシン受容体剤
SK14052003A3 (sk) Použitie derivátov adenozínu na prípravu liečiva na liečenie syndrómu inzulínovej rezistencie a diabetu
US5734052A (en) 8-substituted xanthines as selective adenosine receptor agents
US5064947A (en) Selective adenosine reseptor compounds
EP0662975B1 (de) 2-substituierte adenosine mit a-2 rezeptor affinität
EP0390111B1 (de) Selektive Adenosinrezeptor-Verbindungen
US5426101A (en) 2-substituted adenosines with A-2 receptor affinity

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees